Announcements Trials

Browse Landscape

Phase

Phase NA 1 Phase 4 1 Phase 3 1 Phase 2 1

Status

Completed 7 Recruiting 5 Unknown 3 Withdrawn 1 Terminated 1 Enrolling by invitation 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 412 Carcinoma, Non-Small-Cell Lung 285 Prostatic Neoplasms 208 Neoplasms 202 Neoplasm Metastasis 179 Melanoma 164 Multiple Myeloma 158 Colorectal Neoplasms 157 Leukemia, Myeloid, Acute 143 Lung Neoplasms 132 Leukemia 126 Lymphoma 118 Pancreatic Neoplasms 117 Recurrence 111 Ovarian Neoplasms 111 Leukemia, Lymphocytic, Chronic, B-Cell 110 Lymphoma, Non-Hodgkin 104 Carcinoma, Renal Cell 104 Brain Neoplasms 89 Myelodysplastic Syndromes 88 Precursor Cell Lymphoblastic Leukemia-Lymphoma 86 Glioblastoma 84 Lymphoma, Large B-Cell, Diffuse 80 Lymphoma, Follicular 79 Carcinoma, Hepatocellular 79 Head and Neck Neoplasms 77 Squamous Cell Carcinoma of Head and Neck 76 Urinary Bladder Neoplasms 66 Stomach Neoplasms 61 Hodgkin Disease 59

Interventions

Methylphenidate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Terminated × Cognitive Dysfunction × Clear all

NCT02970500 2023-03-23

CogMet

CHU de Quebec-Universite Laval

Phase 2 Terminated

Breast Neoplasms, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon ⚡